GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » YoY EBITDA Growth

CellCura ASA (FRA:C6L) YoY EBITDA Growth : 66.46% (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. CellCura ASA's YoY EBITDA Growth for the quarter that ended in Jun. 2014 was 66.46%.

CellCura ASA's EBITDA per Share for the three months ended in Jun. 2014 was €-0.05.


CellCura ASA YoY EBITDA Growth Historical Data

The historical data trend for CellCura ASA's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA YoY EBITDA Growth Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
YoY EBITDA Growth
Get a 7-Day Free Trial 106.41 -368.08 -28.80 37.57 70.75

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.65 85.19 51.01 91.95 66.46

CellCura ASA YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

CellCura ASA's YoY EBITDA Growth for the fiscal year that ended in Dec. 2013 is calculated as:

YoY EBITDA Growth (A: Dec. 2013 )
=(EBITDA per Share (A: Dec. 2013 )-EBITDA per Share (A: Dec. 2012 ))/ | EBITDA per Share (A: Dec. 2012 ) |
=(-0.401--1.371)/ | -1.371 |
=70.75 %

CellCura ASA's YoY EBITDA Growth for the quarter that ended in Jun. 2014 is calculated as:

YoY EBITDA Growth (Q: Jun. 2014 )
=(EBITDA per Share (Q: Jun. 2014 )-EBITDA per Share (Q: Jun. 2013 )) / | EBITDA per Share (Q: Jun. 2013 )) |
=(-0.054--0.161)/ | -0.161 |
=66.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of CellCura ASA's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines